US Patent

US11969403 — Topical formulations of chloroprocaine and methods of using same

Formulation · Assigned to Sintetica SA · Expires 2039-05-14 · 13y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects topical formulations of chloroprocaine and methods of using them, particularly for ophthalmic procedures or injuries.

USPTO Abstract

Topical dosages and formulations of chloroprocaine and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy, particularly during ophthalmic procedures or in response to ophthalmic abrasions or trauma.

Drugs covered by this patent

chloroprocaine-hydrochloride (CHLOROPROCAINE HYDROCHLORIDE)

Patent Metadata

Patent number: US11969403
Jurisdiction: US
Classification: Formulation
Expires: 2039-05-14
Drug substance claim: No
Drug product claim: Yes
Assignee: Sintetica SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.